Literature DB >> 2665912

Alzheimer's disease. Sleep and sleep/wake patterns.

M V Vitiello1, P N Prinz.   

Abstract

Significant changes in sleep/wake patterns, particularly loss of SWS and increased amount and frequency of nighttime wakefulness, apparently occur even at an early stage of the AD process. These disruptions of nighttime sleep increase in magnitude with increasing severity of dementia. While the REM sleep of early stage AD patients is relatively unaffected by the disease process, later stages of AD are marked by significant losses of REM sleep and perhaps more importantly the breakdown of the sleep/wake circadian rhythm with significant amounts of sleep occurring during the day. This daytime sleep is of poor quality however, consisting almost exclusively of stages 1 and 2 sleep and does not compensate for the nighttime losses of SWS and REM sleep experienced by AD patients. These findings clearly support the clinical observations and anecdotal reports of sleep disturbance in AD patients. It is of interest to note that sleep is disrupted quite early in the disease process. In our study of early stage AD patients all were community dwelling and had relatively mild cognitive impairment (average MMS scores of 22.7). Despite this, significant increases in frequency and duration of awakening from sleep and reductions of SWS were observed in these patients. These findings indicate that when a patient is suspected of having AD it may be worthwhile as part of the evaluative and diagnostic process to caution both the patient and the patient's family that they might expect to see significant changes in sleep/wake patterns even though the patient's level of day-to-day functioning may still be high. It is also important to consider warning AD patients' families that as the disease progresses they should expect to see not only a worsening of nocturnal sleep quality but a breakdown of the circadian sleep/wake rhythm and an increase in daytime napping behavior by the patient. Families need to be encouraged to try and minimize the napping behavior of the patient in an effort to consolidate sleep into the night. This may have the effect of somewhat attenuating the amount of nocturnal disruption of sleep that accompanies progression of the disease.

Entities:  

Mesh:

Year:  1989        PMID: 2665912

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  35 in total

1.  Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women.

Authors:  Gregory J Tranah; Terri Blackwell; Katie L Stone; Sonia Ancoli-Israel; Misti L Paudel; Kristine E Ensrud; Jane A Cauley; Susan Redline; Teresa A Hillier; Steven R Cummings; Kristine Yaffe
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

2.  Polysomnographic and subjective sleep markers of mild cognitive impairment.

Authors:  Eva Hita-Yañez; Mercedes Atienza; Jose L Cantero
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

Review 3.  Contributions of impaired hippocampal plasticity and neurodegeneration to age-related deficits in hormonal pulsatility.

Authors:  Alexis M Stranahan; Kim Lee; Mark P Mattson
Journal:  Ageing Res Rev       Date:  2008-01-05       Impact factor: 10.895

4.  Qualitative Experience of Sleep in Individuals With Spinal Cord Injury.

Authors:  Donald J Fogelberg; Natalie E Leland; Jeanine Blanchard; Timothy J Rich; Florence A Clark
Journal:  OTJR (Thorofare N J)       Date:  2017-02-14

5.  Update on the Diagnosis and Management of Sleep Disturbances in Dementia.

Authors:  Bradley F Boeve
Journal:  Sleep Med Clin       Date:  2008-09

Review 6.  Effects of exercise on sleep in neurodegenerative disease.

Authors:  Adeel A Memon; Juliana J Coleman; Amy W Amara
Journal:  Neurobiol Dis       Date:  2020-04-01       Impact factor: 5.996

7.  Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.

Authors:  Claudio Liguori; Agostino Chiaravalloti; Marzia Nuccetelli; Francesca Izzi; Giuseppe Sancesario; Andrea Cimini; Sergio Bernardini; Orazio Schillaci; Nicola Biagio Mercuri; Placidi Fabio
Journal:  J Neurol       Date:  2017-09-12       Impact factor: 4.849

8.  A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Authors:  Clifford Singer; Rochelle E Tractenberg; Jeffrey Kaye; Kim Schafer; Anthony Gamst; Michael Grundman; Ronald Thomas; Leon J Thal
Journal:  Sleep       Date:  2003-11-01       Impact factor: 5.849

9.  Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease.

Authors:  Erik S Musiek; Meghana Bhimasani; Margaret A Zangrilli; John C Morris; David M Holtzman; Yo-El S Ju
Journal:  JAMA Neurol       Date:  2018-05-01       Impact factor: 18.302

Review 10.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.